
EMBO | EMBL Symposium: Mechanisms of drug resistance and tolerance in bacteria, fungi, and cancer
March 18 to March 21
This conference will take place at EMBL Heidelberg, with the option to attend virtually.
Symposium Overview
Resilience to antimicrobial drugs is a rapidly increasing problem of global health. Similarly, cancer cells that become drug-resistant or tolerant affect therapy outcomes, for instance during cancer chemotherapy. The underlying biological mechanisms of tolerance, resistance, and persistence are increasingly being studied and reveal a complex interplay between (cellular) evolution, biochemistry, and metabolism. Understanding these mechanisms holds the long-term promise of developing new therapeutic strategies less prone to drug resistance and, in the short term, enhances our understanding of clonal evolution and single-cell biology. With this new symposium, we aim to gather a highly international group of researchers to exchange in-person on the latest work on the biological mechanisms that mediate drug resistance and tolerance across the species barriers.
Session topics
- 1: Molecular targets and mechanisms of tolerance and resistance
- 2: Resistance and tolerance mechanisms of microbiomes and commensals
- 3: Resistance and tolerance mechanisms, single cell biology, persistence & clonal evolution
- 4: Resistance and tolerance mechanisms: the role of efflux and drug transport
- 5: Molecular genetics of resistance and tolerance mechanisms
- 6: The role of macro- and microenvironment on resistance & tolerance mechanisms
Deadlines
JAN 19: Abstract Submission (poster only)
FEB 4: Registration (On-site)
MAR 11: Registration (Virtual)
On-site Registration | Virtual Registration
#EESDrugResistance